GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (XTER:COP) » Definitions » Cash Conversion Cycle

CompuGroup Medical SE KgaA (XTER:COP) Cash Conversion Cycle : -94.27 (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is CompuGroup Medical SE KgaA Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

CompuGroup Medical SE KgaA's Days Sales Outstanding for the three months ended in Mar. 2025 was 59.7.
CompuGroup Medical SE KgaA's Days Inventory for the three months ended in Mar. 2025 was 30.57.
CompuGroup Medical SE KgaA's Days Payable for the three months ended in Mar. 2025 was 184.54.
Therefore, CompuGroup Medical SE KgaA's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2025 was -94.27.


CompuGroup Medical SE KgaA Cash Conversion Cycle Historical Data

The historical data trend for CompuGroup Medical SE KgaA's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA Cash Conversion Cycle Chart

CompuGroup Medical SE KgaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only -44.50 -90.17 -111.25 -101.14 -93.48

CompuGroup Medical SE KgaA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -83.91 -75.28 -57.67 -64.55 -94.27

Competitive Comparison of CompuGroup Medical SE KgaA's Cash Conversion Cycle

For the Health Information Services subindustry, CompuGroup Medical SE KgaA's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CompuGroup Medical SE KgaA's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CompuGroup Medical SE KgaA's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where CompuGroup Medical SE KgaA's Cash Conversion Cycle falls into.


;
;

CompuGroup Medical SE KgaA Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

CompuGroup Medical SE KgaA's Cash Conversion Cycle for the fiscal year that ended in Dec. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=54.13+32.46-180.07
=-93.48

CompuGroup Medical SE KgaA's Cash Conversion Cycle for the quarter that ended in Mar. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=59.7+30.57-184.54
=-94.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CompuGroup Medical SE KgaA  (XTER:COP) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


CompuGroup Medical SE KgaA Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.
Executives
Daniela Hommel CFO, Managing director of the general partner of the issuer
Michael Rauch Managing director of the general partner of the issuer
Emanuele Mugnani Managing director of the general partner of the issuer
Frank Gotthardt Chairman of Administrative Board of CompuGroup Medical Management SE
Prof. (apl.) Dr. Med Daniel Gotthardt Member of the Administrative Board of CompuGroup Medical Management SE
Hannes Reichl Managing director of the general partner of the issuer
Dr. Eckart Pech Managing director of the general partner of the issuer
Dr. Dirk Wössner CEO, Managing director of the general partner of the issuer
Dr. Ralph Körfgen Managing director of the general partner of the issuer